Funding

Research funding news

2022 NHMRC Synergy Grant "Mining the host-pathogen interface to deliver a drug pipeline for treating intractable and emerging infections"

Read more

2022 NHMRC Investigator Grant success!

"Inflammasome inhibitors as new first-in-class anti-inflammatory therapies” 

2022 NHMRC Investigator Grant Inflammation drives many devastating human diseases, and there are currently no effective treatments for many such diseases.

Read more

The Inflammasome lab congratulates Rebecca Coll, a past member of our lab, for winning the ICIS New Investigator Award!  

Read more

We are excited to announce the award of a University of Queensland, Early Career Researcher (UQ, ECR) grant, to Inflammasome Lab's Larisa Labzin!  

Read more

Congratulations to Sabrina Sofia Burgener from the Inflammasome Lab for being granted the Swiss National Science Foundation (SNSF) Early Postdoc Mobility Fellowship.  

Read more

Congratulations to Inflammasome Lab's Mercedes Monteleone for being awarded the ARC Discovery Early Career Researcher Award (DECRA)!  

Read more

New Therapeutic Pipeline Program Grant from the Michael J. Fox Foundation to block inflammasome-induced neuroinflammation in Parkinson's disease

Part of the research team who discovered MCC950 - a small molecule inflammasome inhibitor - has been awarded a Therapeutic Pipeline Program Grant from the Michael J. Fox Foundation for Parkinson's Research.  

Read more

This project will reveal how the body produces interleukin-1β – a protein at the heart of inflammation and disease – so we can design better strategies for treating patients with inflammation driven disease

We are excited to announce that Associate Professor Kate Schroder, has been awarded funding to explore a novel mechanism for IL-1β secretion.Th

Read more

Funding for Parkinson's research

"There is mounting evidence that people with Parkinson’s develop brain inflammation, which accompanies the loss of dopamine-producing brain cells seen in the disease. Our aim is to find a medication that will target the immune response that causes inflammation in the brain, to slow down and hopefully halt disease progression. Our hope for the future is to take these drugs into human clinical trials for Parkinson’s treatment, and we are very grateful to The Michael J. Fox and Shake It Up Australia foundations for funding our research," Associate Professor Woodruff said.

A UQ collaboration including Kate Schroder has been awarded a research grant from The Michael J. Fox Foundation for Parkinson's Research.

Read more